RAC Charts, page-1966

  1. 1,635 Posts.
    lightbulb Created with Sketch. 13916

    My man, how many times do you need to be shown the same thing before it sinks in?

    I have linked this systematic review detailing all P1 trials conducted prior to 2020 for Oncolytic Viruses multiple times: Clinical Application of Oncolytic Viruses- A Systematic Review.pdf

    I collated all the compounds that achieved a response from the phase 1 section alongside CF33. Plenty of OV therapies are contained within that list achieved a CR and none of them have been successful commercially. Even CG0070 is still in clinical development after a near 50% CR rate in Bladder cancer at P1 - Why? Because the market is extremely competitive.

    https://hotcopper.com.au/data/attachments/6719/6719747-d48b680f467ff8c204a8b7455a357ce4.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.22
Change
-0.070(5.45%)
Mkt cap ! $211.9M
Open High Low Value Volume
$1.29 $1.29 $1.21 $186.2K 149.8K

Buyers (Bids)

No. Vol. Price($)
2 9599 $1.22
 

Sellers (Offers)

Price($) Vol. No.
$1.24 1214 1
View Market Depth
Last trade - 14.01pm 24/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.